论文部分内容阅读
“做药业,有着64年历史的公司在我手里得到长足发展,公司连续20年以5%-20%速度实现销售收入增长,现在年上缴税金突破两亿元;做代表,我把民生现实问题带到全国人大会议,引起相关部门高度重视。”这是第十二届全国人大代表、颈复康药业集团董事长李沈明掷地有声的话语。做风湿骨病中药第一品牌学化工搞技术出身的李沈明,有着太多与众不同的地方。他没有显赫的家世背景,没有出国留洋的经历,大学毕业后,不挑不拣,来到了当时效益一般的承德中药厂,扎根奋斗二十几年。
“Pharmaceutical, a 64-year-old company has made great strides in my hands, the company for 20 consecutive years to 5% -20% speed sales revenue growth, the annual tax payment exceeded 200 million yuan; as a representative, I put People’s livelihood issues brought to the NPC session, causing the relevant departments attach great importance. ”This is the Twelfth National People’s Congress, Jinku Pharmaceutical Group chairman Li Shenming rhetoric. Rheumatoid bone disease first brand of traditional Chinese medicine science and technology to engage in chemical origin Li Shenming, there are too many different places. He did not have a prominent family background, there is no experience of going abroad to stay abroad, after graduating from college, do not pick and choose, came to the benefit of Chengde traditional Chinese medicine factory, rooted struggle twenty years.